Literature DB >> 15653314

Viral immune evasion molecules attack the ER peptide-loading complex and exploit ER-associated degradation pathways.

Lonnie Lybarger1, Xiaoli Wang, Michael Harris, Ted H Hansen.   

Abstract

The CD8+ cytotoxic-T-cell response is a potent mechanism that controls intracellular pathogens, including many viruses. To facilitate transmission, viruses often counter this response by inhibiting the cell surface display of virus-derived peptides on MHC class I molecules. More specifically, recent studies have demonstrated that viruses have evolved remarkable mechanisms to inhibit MHC class I expression by interfering with the function of the MHC class I assembly machinery (the peptide-loading complex) in the endoplasmic reticulum and/or by exploiting endoplasmic-reticulum-associated degradation pathways. These viral molecules are proving invaluable as research tools to illuminate the novel features of physiological pathways that are central to normal cell biology. Furthermore, the detailed characterization of such pathways has yielded significant new insights into host-pathogen interplay.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15653314     DOI: 10.1016/j.coi.2004.11.009

Source DB:  PubMed          Journal:  Curr Opin Immunol        ISSN: 0952-7915            Impact factor:   7.486


  13 in total

1.  Kaposi sarcoma herpesvirus K5 removes CD31/PECAM from endothelial cells.

Authors:  Mandana Mansouri; Janet Douglas; Patrick P Rose; Kristine Gouveia; Gary Thomas; Robert E Means; Ashlee V Moses; Klaus Früh
Journal:  Blood       Date:  2006-04-06       Impact factor: 22.113

Review 2.  Herpesvirus interference with major histocompatibility complex class II-restricted T-cell activation.

Authors:  Emmanuel J Wiertz; Robert Devlin; Helen L Collins; Maaike E Ressing
Journal:  J Virol       Date:  2006-11-01       Impact factor: 5.103

Review 3.  MHC class I antigen presentation: learning from viral evasion strategies.

Authors:  Ted H Hansen; Marlene Bouvier
Journal:  Nat Rev Immunol       Date:  2009-07       Impact factor: 53.106

4.  Equine herpesvirus type 4 UL56 and UL49.5 proteins downregulate cell surface major histocompatibility complex class I expression independently of each other.

Authors:  Abdelrahman Said; Walid Azab; Armando Damiani; Nikolaus Osterrieder
Journal:  J Virol       Date:  2012-05-23       Impact factor: 5.103

5.  Inhibition of antigen presentation during AAV gene therapy using virus peptides.

Authors:  Wenwei Shao; Xiaojing Chen; Richard J Samulski; Matthew L Hirsch; Chengwen Li
Journal:  Hum Mol Genet       Date:  2018-02-15       Impact factor: 6.150

6.  Adenovirus RIDalphabeta complex inhibits lipopolysaccharide signaling without altering TLR4 cell surface expression.

Authors:  Fernando Delgado-Lopez; Marshall S Horwitz
Journal:  J Virol       Date:  2006-07       Impact factor: 5.103

Review 7.  Antigen presentation and the ubiquitin-proteasome system in host-pathogen interactions.

Authors:  Joana Loureiro; Hidde L Ploegh
Journal:  Adv Immunol       Date:  2006       Impact factor: 3.543

8.  A short isoform of human cytomegalovirus US3 functions as a dominant negative inhibitor of the full-length form.

Authors:  Jinwook Shin; Boyoun Park; Sungwook Lee; Youngkyun Kim; Bonita J Biegalke; Seongman Kang; Kwangseog Ahn
Journal:  J Virol       Date:  2006-06       Impact factor: 5.103

Review 9.  Viral and cellular MARCH ubiquitin ligases and cancer.

Authors:  Xiaoli Wang; Roger A Herr; Ted Hansen
Journal:  Semin Cancer Biol       Date:  2008-10-02       Impact factor: 15.707

10.  Ubiquitination of serine, threonine, or lysine residues on the cytoplasmic tail can induce ERAD of MHC-I by viral E3 ligase mK3.

Authors:  Xiaoli Wang; Roger A Herr; Wei-Jen Chua; Lonnie Lybarger; Emmanuel J H J Wiertz; Ted H Hansen
Journal:  J Cell Biol       Date:  2007-05-14       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.